Pharmabiz1h
SynCardia Systems gets CNIPA notification granting first patent covering company’s next-generation total artificial heart
SynCardia Systems gets CNIPA notification granting first patent covering company’s next-generation total artificial heart: Tucson, Arizona Saturday, January 11, 2025, 15:00 Hrs ...
Pharmabiz2h
Gaelic Labs establishes subsidiary in UAE, enabling access to growing Middle East pharma market
Gaelic Labs establishes subsidiary in UAE, enabling access to growing Middle East pharma market: Ireland Saturday, January 11, 2025, 13:30 Hrs [IST] Gaelic Laboratories, a Europea ...
Pharmabiz2h
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology: Ingelheim Saturday, January 11, 2025, 14:00 Hrs [IST] Boehringer Ingelheim and Synaf ...
Pharmabiz4h
US FDA grants priority review status to Johnson & Johnson’s nipocalimab BLA to treat generalized myasthenia gravis
US FDA grants priority review status to Johnson & Johnson’s nipocalimab BLA to treat generalized myasthenia gravis: Spring House, Pennsylvania Saturday, January 11, 2025, 12:00 ...
Pharmabiz3h
Seven research leaders awarded prestigious NIHR award
The NIHR has announced the latest outstanding researchers to become NIHR Research Professors. They will play a key role in undertaking professorial-level research that has a positive impact on the ...
Pharmabiz6h
Astellas Pharma announces US FDA confirms Class 1 resubmission of the sNDA for Izervay for geographic atrophy
Astellas Pharma announces US FDA confirms Class 1 resubmission of the sNDA for Izervay for geographic atrophy: Tokyo Saturday, January 11, 2025, 10:00 Hrs [IST] Astellas Pharma In ...
Pharmabiz4d
Eton Pharma acquires Galzin, an US FDA approved treatment of ultra-rare metabolic condition of Wilson disease
Eton Pharmaceuticals, Inc, an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced that it has acquired Galzin (zinc acetate). “This ...
Pharmabiz7d
Centre notifies amendments to Foreign Trade Policy 2023 to enhance stakeholder engagement
The Union ministry of commerce & industry has issued a notification introducing amendments to the Foreign Trade Policy (FTP) 2023, aimed at fostering enhanced stakeholder engagement. The notification, ...
Pharmabiz7h
US FDA accepts for review GSK’s Shingrix new prefilled syringe presentation
US FDA accepts for review GSK’s Shingrix new prefilled syringe presentation: London, UK Saturday, January 11, 2025, 09:00 Hrs [IST] GSK plc, a global biopharma company, announce ...
Pharmabiz7d
GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps
GSK plc announced that the China National Medical Products Administration (NMPA) has approved Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5), as an add-on therapy with ...
Pharmabiz5d
ICMR-NIRDHDS to host workshop on “A Beginner’s Guide to Medical Imaging for Early Diagnosis"
The Indian Council of Medical Research's (ICMR) National Institute for Research in Digital Health and Data Science (NIRDHDS) will host a two-day workshop on “Unlocking AI for Healthcare: A Beginner’s ...
Pharmabiz5d
Parliamentary panel asks DoE to furnish justification on denying proposal for setting up of NIMERs
Expressing its concern over the Department of Expenditure's (DoE) decision to turn down the Department of Pharmaceuticals (DoP)’s proposal for setting up separate National Institutes for Medical ...